has partnered with AEON Clinical Laboratories to nationally launch Cancer Detect Profile(R), a 38-gene cancer genetic test coupled with telehealth-based genetic counseling for the prescribing physicians. The test is designed to identify patients with increased risk of colorectal, breast, pancreatic, ovarian, gastric, melanoma, stomach and other cancers. The test is now available for use by AEON's base of more than 6,000 physicians who annually treat more than one million patients nationwide.
1/3 price and they now have a deal, better trade up ;0) Tomorrow will be HUGE!
Momo traders find it as the day continues on
Panic sellers, lol, thank you, thank you
Look for big move over $7 here now, on the way back to $10
Next leg going to be big, after .135 the chase to .25 begins, tic toc, loading
.14 today imho